• Xconomy Network: Select City or Channel ------------- Boston San Diego Seattle ------------- National Life Sciences Startups
• Xconomy National
• About
• Contact Us
• Archives
• Advertise
• Reprints
• E-mail - RSS

• SEARCH
• Boston
• San Diego
• Seattle
• Life Sciences
• Startups
• Xconomists

From Allozyne, Developer of Multiple Sclerosis Drug in Fewer Shots, Poised to Enter Clinical Trials:

allozyne1—

Allozyne is developing an MS drug that can be given in fewer injections

    

UNDERWRITERS AND PARTNERS

ADVERTISEMENT

Most Popular Stories

• Build it Boldly, and Pharma Will...
• My Worst Boss Ever: Hard-Earned...
• The Story of Google Friend Connect:...
• Kendall Square Adopts a Motto: “The...
• Startup Failure: Seattle’s Stigma,...
• Under the Radar Deals: 10 New England...
• Reactions to President Obama's Energy...
• Negroponte Outlines the Future of...
• Internet Archive Opens 1.6 Million...
• The Litl Computer That Could? Boston...

ADVERTISEMENT

• Home
• Privacy/DMCA
• About
• Contact Us
• Archives
• Advertise
• RSS

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.